QUINTILES TRANSNATIONAL CORPORATION

Lobbying Spend

—

Filings

Firms Hired

Active Period

1999–2020

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2020	—	4	1
2019	—	4	1
2018	—	4	1
2017	—	4	1
2016	—	5	1
2015	—	4	1
2014	—	5	1
2013	—	5	1
2012	—	4	1
2011	—	4	1
2010	—	4	1
2009	—	7	1
2008	—	4	1
2007	—	2	1
2006	—	2	1
2005	—	1	1
2004	—	1	1
2003	—	1	1
2002	—	2	1
2001	—	1	1
1999	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
WASHINGTON HEALTH STRATEGIES GROUP	—	54
WASHINGTON HEALTH ADVOCATES	—	18

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	67
SENATE	67
Food & Drug Administration (FDA)	50
Health & Human Services, Dept of (HHS)	37
Government Accountability Office (GAO)	5
Homeland Security, Dept of (DHS)	3
Centers For Disease Control & Prevention (CDC)	2
Centers For Medicare and Medicaid Services (CMS)	1
Drug Enforcement Administration (DEA)	1
Natl Institutes of Health (NIH)	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	68
Homeland Security	Homeland Security	3
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	2

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 6114th Congress

21st Century Cures Act

Cited source text and reported amounts

Conduct of Clinical Trials, Drug Safety, Corporate Tax Reform, FDA, 21st Century Cures, HR 6 21st Century Cures Act

Client expense: — · Firm income: $40,000

Matched citations: HR 6

QUINTILES TRANSNATIONAL CORPORATION — Lobbying Disclosure | Poliscope